Vimarsana
Biggest News Aggregation in the World

Page 24 - Recent Highlights News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recent Highlights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recent Highlights Today - Breaking & Trending Today

Ondas Holdings Inc.: Ondas Holdings Reports First Quarter 2022 Financial and Operational Results - Vimarsana News

Ondas Holdings Inc.: Ondas Holdings Reports First Quarter 2022 Financial and Operational Results

Ondas Holdings Affirms 2022 Financial and Operational OutlookOndas Networks Prepares for FullMAX Platform Deployment with North American Class I Rails in 900 MHz NetworkAmerican Robotics Building Strong

Aurinia Reports First Quarter 2022 Financial and Operational Results - Vimarsana News

Aurinia Reports First Quarter 2022 Financial and Operational Results

10.05.2022 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the first quarter ended March 31, 2022. Amounts, unless specified otherwise, are expressed in U.S. dollars. Net product revenues were $21.6 ...

F-star Therapeutics, Inc.: F-star Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

F-star Therapeutics, Inc.: F-star Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update

Four Clinical Readouts Anticipated Throughout 2022 Mechanistic Data on FS118 Demonstrating Shedding Mechanism and LAG-3 Reduction Presented at the 2022 American Association for Cancer Research (AACR)

Sonim Reports First Quarter Financial Results - Vimarsana News

Sonim Reports First Quarter Financial Results

/PRNewswire/ -- Sonim Technologies, Inc. (Nasdaq: SONM), a leading U.S. provider of ultra-rugged mobile devices, accessories and solutions designed...

F-star Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

F-star Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update

F-star Therapeutics, Inc. (NASDAQ: FSTX) (“F-star” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer, today announced first quarter 2022 financial results and provided a corporate update ...